#Astaxanthin Market Share

[marketanalysisdata]

Astaxanthin Market Share and Growth Information Analysis Report by 2030

The global astaxanthin market was valued at USD 2.34 billion in 2023, with a projected compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by rising demand across multiple sectors, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin is particularly valued in aquaculture as a feed ingredient for prawns, salmon, trout, and ornamental fish to enhance their coloration, which increases their commercial appeal. Besides improving pigmentation, astaxanthin also contributes to enhanced stress tolerance, improved performance, immune support, reproductive health, increased survival rates, and disease resistance in aquatic animals. To meet this demand, major market players are focusing on product innovation and forming partnerships, especially in the aquaculture sector.

Organizations promoting awareness about astaxanthin’s applications further support market growth. The Natural Algae Astaxanthin Association (NAXA), for example, plays a significant role in advocating for natural astaxanthin, promoting its benefits across various industries, supporting research, and certifying products with the NAXA Verification Seal.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

To expand market reach, companies are leveraging strategies such as product launches and collaborations with leading firms in key industries. For example, in May 2022, Algalif partnered with Divi’s Nutraceuticals to launch AstaBeads, a high-concentration astaxanthin beadlet targeting sports nutrition and healthy aging applications. This collaboration is poised to boost market penetration of natural astaxanthin products. Furthermore, The Lubrizol Corporation introduced ASTAGILE microcapsules in October 2020 to promote cognitive health and agility for both young and elderly consumers.

In May 2022, Algalif and Divi’s Nutraceuticals collaborated on producing high-concentration natural astaxanthin beadlets. Based in Iceland, Algalif uses a renewable-energy-powered process to produce high-quality astaxanthin oleoresin from microalgae. Divi’s Nutraceuticals then applies its expertise in fat-soluble ingredients to transform this oleoresin into AstaBead beadlets, which contain a concentrated 5% astaxanthin. This partnership emphasizes both sustainability and premium product quality, showcasing a commitment to environmental stewardship and product excellence.

Application Segmentation Insights:

In 2023, the aquaculture and animal feed sector held the largest market share at 46.39%, primarily due to astaxanthin’s extensive use as a feed additive to enhance reddish pigmentation in species like salmon, trout, and shrimp, which is a key consumer preference. Astaxanthin oil also promotes better feed uptake, accelerating shrimp growth. The growing adoption of astaxanthin in the aquaculture sector to improve seafood quality supports this segment’s dominance in the market. Leading players are also launching new products with health benefits for animal feed. For instance, AstaReal introduced Novasta in July 2022, an astaxanthin-based ingredient for animal feed, expanding health-focused applications in animal nutrition.

The nutraceuticals segment is anticipated to experience the fastest CAGR during the forecast period, driven by increasing demand for natural astaxanthin in health supplements due to its superior antioxidant properties compared to other supplements. The rising need for nutritional products, alongside aging populations, nutrient deficiencies, and lifestyle-related health concerns, is boosting demand in this sector. Astaxanthin’s antioxidant benefits are linked to support against conditions like liver and oral cancers, cardiovascular diseases, and obesity. Thus, the growing prevalence of chronic and infectious diseases is expected to provide substantial growth opportunities for the nutraceuticals market.

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Astaxanthin Market - Recent Industry Developments and Growth Strategies till 2030

The global astaxanthin market was valued at USD 2.34 billion in 2023, with a projected compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by rising demand across multiple sectors, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin is particularly valued in aquaculture as a feed ingredient for prawns, salmon, trout, and ornamental fish to enhance their coloration, which increases their commercial appeal. Besides improving pigmentation, astaxanthin also contributes to enhanced stress tolerance, improved performance, immune support, reproductive health, increased survival rates, and disease resistance in aquatic animals. To meet this demand, major market players are focusing on product innovation and forming partnerships, especially in the aquaculture sector.

Organizations promoting awareness about astaxanthin’s applications further support market growth. The Natural Algae Astaxanthin Association (NAXA), for example, plays a significant role in advocating for natural astaxanthin, promoting its benefits across various industries, supporting research, and certifying products with the NAXA Verification Seal.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

To expand market reach, companies are leveraging strategies such as product launches and collaborations with leading firms in key industries. For example, in May 2022, Algalif partnered with Divi’s Nutraceuticals to launch AstaBeads, a high-concentration astaxanthin beadlet targeting sports nutrition and healthy aging applications. This collaboration is poised to boost market penetration of natural astaxanthin products. Furthermore, The Lubrizol Corporation introduced ASTAGILE microcapsules in October 2020 to promote cognitive health and agility for both young and elderly consumers.

In May 2022, Algalif and Divi’s Nutraceuticals collaborated on producing high-concentration natural astaxanthin beadlets. Based in Iceland, Algalif uses a renewable-energy-powered process to produce high-quality astaxanthin oleoresin from microalgae. Divi’s Nutraceuticals then applies its expertise in fat-soluble ingredients to transform this oleoresin into AstaBead beadlets, which contain a concentrated 5% astaxanthin. This partnership emphasizes both sustainability and premium product quality, showcasing a commitment to environmental stewardship and product excellence.

Application Segmentation Insights:

In 2023, the aquaculture and animal feed sector held the largest market share at 46.39%, primarily due to astaxanthin’s extensive use as a feed additive to enhance reddish pigmentation in species like salmon, trout, and shrimp, which is a key consumer preference. Astaxanthin oil also promotes better feed uptake, accelerating shrimp growth. The growing adoption of astaxanthin in the aquaculture sector to improve seafood quality supports this segment’s dominance in the market. Leading players are also launching new products with health benefits for animal feed. For instance, AstaReal introduced Novasta in July 2022, an astaxanthin-based ingredient for animal feed, expanding health-focused applications in animal nutrition.

The nutraceuticals segment is anticipated to experience the fastest CAGR during the forecast period, driven by increasing demand for natural astaxanthin in health supplements due to its superior antioxidant properties compared to other supplements. The rising need for nutritional products, alongside aging populations, nutrient deficiencies, and lifestyle-related health concerns, is boosting demand in this sector. Astaxanthin’s antioxidant benefits are linked to support against conditions like liver and oral cancers, cardiovascular diseases, and obesity. Thus, the growing prevalence of chronic and infectious diseases is expected to provide substantial growth opportunities for the nutraceuticals market.

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Astaxanthin Market Segmentation and Competitive Analysis Report 2024 - 2030

The global astaxanthin market size was valued at USD 2.34 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. 

Growing demand for astaxanthin is being fueled by its increasing use in various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages, among others. It is widely used as a food ingredient for prawns and fishes such as salmon, trout, & ornamental fishes to enhance their coloration and increase commercial value. Other benefits for aquatic animals include growth in stress tolerance, performance, immune-related gene expressions, reproductive capacity, improvement in survival, and disease resistance. Major players are focusing on new product developments and collaborative agreements to meet the increasing demand for astaxanthin in aquaculture.

Additionally, presence of organizations that actively promote awareness regarding diverse applications of these products is expected to further drive market growth. For instance, the Natural Algae Astaxanthin Association (NAXA) plays a key role in promoting, protecting, and educating about the benefits of natural astaxanthin in various end-use applications.The association supports research related to natural astaxanthin and certifies products with NAXA Verification Seal.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

Astaxanthin Market Report Highlights

• Based on product, the dried algae meal or biomass segment accounted for the largest share in 2023 due to the high usage as animal feed and lower cost of production

• The aquaculture & animal feed segment was the highest revenue contributor in 2023. Whereas, the nutraceuticals segment is expected to exhibit the fastest CAGR during the projected period

• The Asia Pacific region is expected to grow at the fastest rate over the forecast period due to the rising investments by market players and increasing research activities in the region

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• The global antiarrhythmic drugs market size was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030. 

• The global amyloidosis treatment market size was valued at USD 5.39 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030.

Astaxanthin Market Segmentation

Grand View Research has segmented the global astaxanthin market on the basis of source, product, application, and region

Astaxanthin Source Outlook (Revenue, USD Million, 2018 - 2030) (Volumein Metric Tonnes)

• Natural

o Yeast

o Krill/Shrimp

o Microalgae

o Others

• Synthetic

Astaxanthin Product Outlook (Revenue, USD Million, 2018 - 2030)

• Dried Algae Meal or Biomass

• Oil

• Softgel

• Liquid

• Others

Astaxanthin Application Outlook (Revenue, USD Million, 2018 - 2030)

• Nutraceuticals

• Cosmetics

• Aquaculture And Animal Feed

• Food

o Functional Foods And Beverages

o Other Traditional Food Manufacturing Applications

• Others

Astaxanthin Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Italy

o Spain

o Russia

o Denmark

o Norway

o Sweden

• Asia Pacific

o Japan

o China

o India

o South Korea

o Australia

o Singapore

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

o Ecuador

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Israel

o Kuwait

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[credenceresearchdotblog]

The Astaxanthin Market is projected to grow from USD 274.7 million in 2024 to an estimated USD 571.93 million by 2032, with a compound annual growth rate (CAGR) of 9.6% from 2024 to 2032.Astaxanthin, a powerful antioxidant derived from microalgae, yeast, shrimp, salmon, and other marine sources, has gained significant traction in the global market due to its health benefits and diverse applications. Known for its vibrant red pigment and exceptional antioxidant properties, astaxanthin is increasingly utilized in dietary supplements, cosmetics, aquaculture, and pharmaceuticals. The global astaxanthin market is experiencing substantial growth, driven by rising consumer awareness about wellness, the expansion of the nutraceuticals sector, and the ongoing search for sustainable, natural solutions.

Browse the full report https://www.credenceresearch.com/report/astaxanthin-market

Market Overview and Growth Drivers

The astaxanthin market was valued at over USD 800 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of more than 6% from 2024 to 2030. Several factors contribute to this robust growth trajectory:

Health and Wellness Trends Increasing consumer awareness of the health benefits of antioxidants has been a significant market driver. Astaxanthin is renowned for its ability to reduce oxidative stress, improve skin health, enhance immune function, and support cardiovascular health. These benefits have propelled its demand in the nutraceutical and functional food sectors.

Rising Popularity in Cosmetics The cosmetic industry has embraced astaxanthin due to its anti-aging and skin-protective properties. It is widely used in skincare products to reduce wrinkles, improve skin elasticity, and protect against UV damage. With the growing demand for natural and organic cosmetics, astaxanthin’s market share in this segment is expanding.

Aquaculture and Animal Feed Applications Astaxanthin is a vital feed additive in aquaculture, particularly in salmon farming, to enhance pigmentation and improve the nutritional quality of fish. As global aquaculture production increases, the demand for astaxanthin in this sector is also rising.

Pharmaceutical Applications Emerging research into the therapeutic potential of astaxanthin for managing conditions like inflammation, eye disorders, and neurodegenerative diseases has spurred interest in its use in pharmaceuticals.

Challenges and Opportunities

Despite its promising growth, the astaxanthin market faces challenges such as high production costs and limited consumer awareness in certain regions. Natural astaxanthin production, while environmentally friendly, involves complex and expensive cultivation and extraction processes. Synthetic alternatives, though cheaper, are often viewed as less desirable by health-conscious consumers.

The development of cost-effective, sustainable production technologies presents significant opportunities for market players. Advances in microalgae farming, including the use of photobioreactors and genetic engineering, are expected to reduce production costs and improve yield. Additionally, increasing investment in research and development to explore new applications of astaxanthin could unlock further market potential.

Future Outlook

The future of the astaxanthin market looks bright, driven by a growing emphasis on preventive healthcare, sustainable aquaculture practices, and natural beauty products. As consumers increasingly prioritize wellness and eco-friendly solutions, astaxanthin is poised to become a key player in the global health and wellness ecosystem.

Key Player Analysis:

Algatech Ltd

MicroA

Cyanotech Corporation

Algalíf Iceland ehf

Beijing Gingko Group (BGG)

PIVEG, Inc.

Fuji Chemical Industries Co., Ltd

ENEOS Corporation

Atacama Bio Natural Products S.A.

E.I.D. – Parry (India) Limited (Alimtec S.A., Valensa International)

Segmentation:

Based on Product Type:

Natural Astaxanthin

Synthetic Astaxanthin

Based on Technology:

Algae-Based Production

Chemical Synthesis

Based on End-User:

Food & Beverages

Dietary Supplements

Cosmetics

Pharmaceuticals

Based on Region:

North America

United States

Canada

Mexico

Europe

Germany

France

United Kingdom

Italy

Spain

Asia Pacific

China

Japan

India

South Korea

Australia

Latin America

Brazil

Argentina

Chile

Mexico

Middle East & Africa

United Arab Emirates

Saudi Arabia

South Africa

Egypt

Browse the full report https://www.credenceresearch.com/report/astaxanthin-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[latestmarketresearchnews]

Astaxanthin Market Size & Share | Statistics Report 2030

The global astaxanthin market reached a valuation of USD 2.34 billion in 2023, with projections indicating a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by a rising demand for astaxanthin across various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin’s role in aquaculture is significant, where it is commonly used to enhance the coloration of species such as prawns, salmon, trout, and ornamental fish, increasing their market value. Additionally, astaxanthin offers numerous health benefits to aquatic animals, improving stress tolerance, performance, immune-related gene expression, reproductive capacity, survival rates, and disease resistance. To meet the rising demand in aquaculture, major industry players are focusing on product development and collaborative agreements.

Market growth is further supported by organizations that actively promote awareness of astaxanthin's diverse applications. For example, the Natural Algae Astaxanthin Association (NAXA) is influential in promoting, protecting, and educating the public on the benefits of natural astaxanthin across various industries. NAXA also supports relevant research and offers the NAXA Verification Seal to certify natural astaxanthin products.

To increase the penetration of natural astaxanthin-based products, companies are engaging in strategies such as new product launches and partnerships with influential players in related industries. For instance, Algalif partnered with Divi’s Nutraceuticals in May 2022 to release high-concentration astaxanthin beadlets called AstaBeads, targeting sports nutrition and healthy aging markets. Similarly, The Lubrizol Corporation launched ASTAGILE microcapsules in October 2020, focusing on enhancing cognitive and mental agility for both young and senior adults.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

The astaxanthin market showcases a high degree of innovation, with companies developing novel formulations and sustainable production methods. For example, Sirio Europe (SIRIO) revealed in August, 2023, its plan to introduce two new softgel products targeting the pharmaceutical sector during the CPHI Barcelona 2023 event.

The astaxanthin market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players In January 2022, ENEOS Corporation disclosed its acquisition of Ecocert Inputs Attestation, a globally recognized certification organization. This strategic move strengthens ENEOS' position in the astaxanthin market, particularly for Panaferd-AX. The merger reflects the company's commitment to quality and international standards, contributing to the evolution of the industry.

Product Segmentation Insights:

In 2023, dried algae meal or biomass dominated the market with a share of 25.26%. This significant share is attributed to its applications in biomass production for other forms, such as capsules and tablets, minimal downstream processing, convenient bulk production, and a higher demand for use as animal feed. New product launches in the sector, such as Solabia-Algatech Nutrition Ltd’s AstaPure Arava gummies in October 2022, highlight the growing demand for algal astaxanthin. Additionally, in May 2022, Algalif collaborated with start-up company Marea to create a biodegradable coating using residual algae biomass. These advancements are anticipated to support growth in this segment over the forecast period.

The softgel segment is expected to experience strong growth in the coming years, as softgels are widely favored by consumers for their convenience and suitability for the geriatric population. Veggie softgels, derived from modified cornstarch and glycerin, are particularly popular among nutraceutical companies due to their plant-based origin and minimal side effects. Regulatory approvals are further boosting this segment; for example, in September 2021, NextFerm Technologies obtained regulatory approval in the U.S. to market Astaferm, an innovative antioxidant in oil form for softgels.

These factors collectively contribute to the expansion of the global astaxanthin market across various segments and applications.

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Astaxanthin Market – Industry Trends and Forecast Report 2030

The global astaxanthin market reached a valuation of USD 2.34 billion in 2023, with projections indicating a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by a rising demand for astaxanthin across various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin’s role in aquaculture is significant, where it is commonly used to enhance the coloration of species such as prawns, salmon, trout, and ornamental fish, increasing their market value. Additionally, astaxanthin offers numerous health benefits to aquatic animals, improving stress tolerance, performance, immune-related gene expression, reproductive capacity, survival rates, and disease resistance. To meet the rising demand in aquaculture, major industry players are focusing on product development and collaborative agreements.

Market growth is further supported by organizations that actively promote awareness of astaxanthin's diverse applications. For example, the Natural Algae Astaxanthin Association (NAXA) is influential in promoting, protecting, and educating the public on the benefits of natural astaxanthin across various industries. NAXA also supports relevant research and offers the NAXA Verification Seal to certify natural astaxanthin products.

To increase the penetration of natural astaxanthin-based products, companies are engaging in strategies such as new product launches and partnerships with influential players in related industries. For instance, Algalif partnered with Divi’s Nutraceuticals in May 2022 to release high-concentration astaxanthin beadlets called AstaBeads, targeting sports nutrition and healthy aging markets. Similarly, The Lubrizol Corporation launched ASTAGILE microcapsules in October 2020, focusing on enhancing cognitive and mental agility for both young and senior adults.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

The astaxanthin market showcases a high degree of innovation, with companies developing novel formulations and sustainable production methods. For example, Sirio Europe (SIRIO) revealed in August, 2023, its plan to introduce two new softgel products targeting the pharmaceutical sector during the CPHI Barcelona 2023 event.

The astaxanthin market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players In January 2022, ENEOS Corporation disclosed its acquisition of Ecocert Inputs Attestation, a globally recognized certification organization. This strategic move strengthens ENEOS' position in the astaxanthin market, particularly for Panaferd-AX. The merger reflects the company's commitment to quality and international standards, contributing to the evolution of the industry.

Product Segmentation Insights:

In 2023, dried algae meal or biomass dominated the market with a share of 25.26%. This significant share is attributed to its applications in biomass production for other forms, such as capsules and tablets, minimal downstream processing, convenient bulk production, and a higher demand for use as animal feed. New product launches in the sector, such as Solabia-Algatech Nutrition Ltd’s AstaPure Arava gummies in October 2022, highlight the growing demand for algal astaxanthin. Additionally, in May 2022, Algalif collaborated with start-up company Marea to create a biodegradable coating using residual algae biomass. These advancements are anticipated to support growth in this segment over the forecast period.

The softgel segment is expected to experience strong growth in the coming years, as softgels are widely favored by consumers for their convenience and suitability for the geriatric population. Veggie softgels, derived from modified cornstarch and glycerin, are particularly popular among nutraceutical companies due to their plant-based origin and minimal side effects. Regulatory approvals are further boosting this segment; for example, in September 2021, NextFerm Technologies obtained regulatory approval in the U.S. to market Astaferm, an innovative antioxidant in oil form for softgels.

These factors collectively contribute to the expansion of the global astaxanthin market across various segments and applications.

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[marketresearchreportinsight]

Astaxanthin Market Size, Share, and Trends Report 2030

The global astaxanthin market reached a valuation of USD 2.34 billion in 2023, with projections indicating a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by a rising demand for astaxanthin across various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin’s role in aquaculture is…

[devan-patel]

Innovative Pet Care: Devan Patel's Natural Solutions

Devan Patel Pharmacist: For pharmacist Devan Patel, the entrepreneurial journey comes from a singular driving force – using the power of natural medicine to promote healing and well-being in both humans and their cherished animal companions. Over his two decades in pharmacy, Devan witnessed how traditional medications sometimes fell short, prompting him to explore alternative botanical therapies.

“I saw natural supplements truly transform my patients’ quality of life, especially those battling complex, multi-symptom conditions,” Devan recounts. “The limitations of mainstream healthcare inspired me to develop therapeutic nutraceuticals and plant-based compounds grounded in rigorous science.” 

This passion for innovative natural remedies led Devan to co-found Zen Nutrients, a company dedicated to creating pharmacist-doctor-formulated supplements backed by evidence-based research, such as The Everyday Liver Vitamin™ with Bergacyn® FF that aims to provide Fatty Liver Support & Liver Health Aid. As a devoted family man with a supportive wife and children, Devan strives to embody the same values of hard work, integrity, and compassion for others instilled in him by his parents.

“From a young age, my wonderful parents taught me the importance of diligence, honesty and genuinely caring about people’s wellbeing,” Devan shares. “Those lessons have guided me as a pharmacist and now as an entrepreneur developing natural health solutions.”

But Devan’s entrepreneurial drive extends far beyond just crafting supplements. It’s a higher calling rooted in family, community, and an unrelenting quest to solve unmet medical needs.

One of Devan’s latest co-developed product innovations is WoundVite® for Dogs – a veterinary mastermind formulation designed to promote healing, strengthen hip and joint health, and support recovery in dogs after surgery or injury.

Co-developed with a surgical veterinarian along with Devan’s pharmaceutical expertise, this product is a game changer in the dog pet industry, being the only product on the market that helps with wound healing, surgery recovery, while also serving as a supreme anti-inflammatory formula for hip and joint maintenance care.

After WoundVite® launched, Devan began hearing stories from dog owners who had given the supplement to their pets – often without their veterinarian’s knowledge about the natural product. To the owners’ surprise and delight, WoundVite® helped their dogs recover from injuries, surgeries and even strengthening their hip and joints in ways they hadn’t found with traditional medications and common dog supplements.

“As a lifelong dog lover who grew up adopting a dog, I’ve been able to see the challenges pet owners face. My own dog suffered from hip dysplasia associated with degenerative joint disease and osteoarthritis, leading me to witness firsthand the unmet need for effective solutions to help with their pain and suffering post surgery. It inspired me to create a product that could truly support our four-legged friends in their times of need,” Devan adds.

Masterfully blending 26 key vitamins, minerals, and herbs like glucosamine, MSM, turmeric, green lipped mussel, hemp seed, bovine collagen, vitamins E, zinc, and C, WoundVite® aims to aid in reducing inflammation, promoting wound recovery, and providing building blocks for the repair of cartilage, connective tissue, and joints. The innovative part is that it also contains a proprietary recovery blend of omega fatty acids, hyaluronic acid, grape seed extract, l-arginine, astaxanthin all co-formulated by a surgical veterinarian to optimize healing and recovery.

“Seeing the impact our science-backed, natural products have on improving lives is immensely gratifying,” Devan states. “It motivates me to keep innovating so we can overcome seemingly intractable health issues across all species.”

While a work in progress, Devan’s ultimate vision along with her core team is for Zen Nutrients’ therapeutic nutraceutical line – including WoundVite® for pets – to be carried by major retailers.

With botanical innovations, integrity, and a passion for preventing and managing chronic conditions, Devan Patel and Zen Nutrients are pioneering the future of integrative health. By synergizing pharmaceutical science with the wisdom of natural medicine, this “pharmapreneur” is pioneering a path forward for the wellness of millions across all species.

Reference link: https://nyweekly.com/business/pharmapreneur-devan-patel-natural-solutions-for-pets/

[foodandbeverages]

Astaxanthin Market: Applications and Regional Insights During the Forecasted Period 2024 to 2034

According to Future Market Insights (FMI), global astaxanthin sales are estimated to be worth USD 273.2 million in 2024. The market is expected to reach USD 665.0 million by 2034. It is projected to surge at a CAGR of 9.3% in the forecast period 2024 to 2034.

Astaxanthin’s increasing demand is driven by its use in aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food & beverages industries. It is widely used as a food ingredient for prawns and fish to enhance coloration and commercial value.

Astaxanthin benefits aquatic animals by increasing stress tolerance, performance, immune-related gene expressions, reproductive capacity, survival, and disease resistance. The market is expected to rise due to the consistent demand from the food industry, where astaxanthin is used as a food additive due to its health benefits, such as anti-inflammatory effects and prevention of cardiovascular diseases. Studies have shown that astaxanthin is set to prevent photo-aging, improve sleep, minimize obesity, protect the vocal cord, combat depression, and increase sperm motility.

Natural alternatives are gaining traction due to a number of factors, including greater awareness of the harmful effects of chemicals and expanding usage of synthetic ingredients in topical & culinary items. As a result, leading companies are implementing tactics, including the introduction of new products and alliances with key manufacturers in several sectors to boost the market share of natural astaxanthin-based products.

Information Source: https://www.futuremarketinsights.com/reports/astaxanthin-market

Key Takeaways from the Astaxanthin Market Report:

The global astaxanthin market is expected to reach a valuation of US$ 665.0 million by 2034.

Japan is projected to hold a dominant value share of 3.5% by 2034.

The United States astaxanthin market is projected to reach a valuation of US$ 177.6 million by 2034.

India’s astaxanthin market is projected to reach US$ 43.0 million by 2034.

Germany is set to hold a dominant value share of 4.1% by 2034.

 “The astaxanthin market is experiencing innovation as dietary lutein becomes a potential substitute in the market. Leading companies are incorporating lutein-rich sources into formulations, highlighting a trend toward diversification. They are also exploring alternative natural compounds.” – says a lead analyst at Future Market Insights (FMI).

Competitive Landscape

BASF SE, Divi’s Laboratories Ltd., Cyanotech Corporation, DSM N.V., Parry Nutraceuticals, and JXTG Nippon Oil & Energy Corporation are key astaxanthin manufacturers listed in the report. Leading companies are concentrating on broadening their portfolios by launching new products. They also use strategies such as advertisements, partnerships, acquisitions, agreements, and mergers to stay relevant in the market.

For instance,

In 2020, BGG declared two key extensions of its farm capacity of astaxanthin as the company has seen a surge in its astaxanthin sales lately.

Key Companies Profiled

BASF SE

Divi’s Laboratories Ltd.

Cyanotech Corporation

DSM N.V

Parry Nutraceuticals

JXTG Nippon Oil & Energy Corporation

Fuji Chemical Industries Co., Ltd.

Kunming Biogenic Co., Ltd.

Valensa International Global

Kailu Ever Brilliance Biotechnology Co. Ltd.

Algalif Iceland Ehf

Zhejiang NHU Co., Ltd.

Atacama Bio Natural Products S.A., Inc.

AstaReal Inc

Fenchem Biotek Ltd.

Igene Biotechnology, Inc.

BGG (Beijing Gingko Group)

Cardax, Inc.

Algatechnologies Ltd.

Algaecan Biotech Ltd.

Otsuka Pharmaceutical Co., Ltd.

Yunnan Alphy Biotech Co., Ltd.

INNOBIO Corporation Limited.

Sinoway Industrial Co., Ltd.

KDI Ingredients

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global astaxanthin market, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034.

The study incorporates compelling insights on the astaxanthin market based on species type (haematococcus pluvialis, chlorococcum, chlorella zofingiensis), production technology (chemical synthesis, natural extraction), form (tablets, soft gel capsules, powder, liquid), grade (>=98%, 95%-97%, <=94%), application (aquaculture, dietary supplements, food & beverages, personal care & cosmetics, pet food), and region.

[industrynewsupdates]

Astaxanthin Market Forecast: Growth, Trends, and Opportunities

The global astaxanthin market was valued at USD 2.34 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is largely driven by the increasing demand for astaxanthin across various sectors, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages.

Astaxanthin is a powerful antioxidant commonly used as a food ingredient in the aquaculture industry, especially for species such as prawns, salmon, trout, and ornamental fish. It enhances the coloration of these aquatic animals, which in turn increases their commercial value. Beyond its cosmetic effects, astaxanthin offers several health benefits for aquatic species. It helps improve stress tolerance, promotes better growth, boosts immune-related gene expressions, supports reproductive capacity, enhances survival rates, and increases disease resistance. Due to these benefits, major companies are intensifying their focus on product development and forming collaborative agreements to cater to the growing demand for astaxanthin in aquaculture.

The astaxanthin market is also characterized by significant innovation, with companies developing new formulations and sustainable production methods to meet the evolving market needs. A notable example of such innovation is Sirio Europe (SIRIO), which, in August 2023, announced plans to introduce two new softgel products targeted at the pharmaceutical sector during the CPHI Barcelona 2023 event. These new products represent a step toward diversifying the application of astaxanthin in different industries.

Additionally, the market is seeing considerable merger and acquisition (M&A) activity among leading companies. In January 2022, ENEOS Corporation made a strategic acquisition of Ecocert Inputs Attestation, a globally recognized certification organization. This move strengthens ENEOS' position in the astaxanthin market, particularly for its product Panaferd-AX. The merger underscores ENEOS' commitment to maintaining high-quality standards and meeting international certifications, which further supports the growth of the astaxanthin market.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market 

Regional Insights:

North America Astaxanthin Market Trends

North America is currently the largest market for astaxanthin, accounting for 36.53% of the global market share in 2023. The region’s demand for astaxanthin is largely driven by the rising prevalence of nutrition-related and skin-related health issues. Moreover, North America is home to major players such as Cyanotech, Piveg, Inc., and Beijing Ginko Group (BGG), as well as synthetic astaxanthin producers like Cardax, Inc.. These companies are expected to drive continued market growth throughout the forecast period. The region also benefits from a large consumer base that is increasingly health-conscious, coupled with a growing adoption of nutraceuticals and a well-established cosmeceutical industry. These factors collectively fuel the increasing demand for astaxanthin products in North America.

Asia Pacific Astaxanthin Market Trends

Asia Pacific, on the other hand, is expected to experience the fastest growth in the astaxanthin market over the forecast period. This growth is supported by increasing production capacities, higher research and development (R&D) expenditures, and strong economic growth in the region. Countries in the Asia Pacific are becoming key manufacturing hubs for astaxanthin, with several companies ramping up production to meet regional demand.

India

In India, the growing prominence of natural ingredients is contributing to the rising popularity of astaxanthin. For example, BodyFirst Wellness Nutrition, an Indian nutraceutical company, launched its range of products both nationwide and internationally after a successful market test. The company has already established a solid presence in North India through partnerships with 15 distributors. Its official launch aims for broader reach, including collaboration with 100 more distributors across India and expanding its global presence through online platforms. The launch highlights the increasing adoption of traditional, natural ingredients, such as ashwagandha and astaxanthin, in India’s burgeoning nutraceutical market.

Browse through Grand View Research's Category Pharmaceuticals Industry Research Reports.

• The global celiac disease treatment market size was valued at USD 582.5 million in 2023 and is projected to grow at a CAGR of 11.8% from 2024 to 2030.

• The global food allergy treatment market size was estimated at USD 6.87 billion in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030.

Key Companies & Market Share Insights:

The astaxanthin market features several key players, including Algatech Ltd., Cyanotech Corporation, and ALGAMO. These companies are enhancing their market positions by expanding into new geographical regions to increase their market share. Additionally, they are focusing on securing market approvals for innovative products aimed at addressing various health conditions.

Emerging players in the market are adopting strategies such as collaborations with research institutes and academic organizations to innovate and bring new products to market. These collaborations are helping to drive forward both product development and the establishment of new contracts, positioning these companies for future growth. Furthermore, the agility of emerging market players allows them to adapt quickly to changing market demands and technological advancements, making them more flexible than their larger, established counterparts.

Key Astaxanthin Companies:

• Algatech Ltd

• MicroA

• Cyanotech Corporation

• Algalíf Iceland ehf

• Beijing Gingko Group (BGG)

• PIVEG, Inc.

• Fuji Chemical Industries Co., Ltd

• ENEOS Corporation

• Atacama Bio Natural Products S.A.

• E.I.D. – Parry (India) Limited (Alimtec S.A., Valensa International)

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.